We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
-0.87%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$46.4B
AUM Growth
+$701M
(+1.5%)
Cap. Flow
+$2.34B
Cap. Flow
% of AUM
5.06%
Top 10 Holdings %
Top 10 Hldgs %
14.53%
Holding
2,237
New
170
Increased
888
Reduced
909
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$197M |
| 2 |
Deckers Outdoor
DECK
|
+$179M |
| 3 |
DexCom
DXCM
|
+$156M |
| 4 |
Teradyne
TER
|
+$154M |
| 5 |
ExxonMobil
XOM
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$163M |
| 2 |
Wingstop
WING
|
+$130M |
| 3 |
ServiceNow
NOW
|
+$108M |
| 4 |
GoDaddy
GDDY
|
+$94.2M |
| 5 |
Vertiv
VRT
|
+$80M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.5% |
| 2 | Healthcare | 16.86% |
| 3 | Financials | 13.55% |
| 4 | Consumer Discretionary | 9.41% |
| 5 | Industrials | 9.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Kyndryl
KD
$2.8B
| $1.52M | ﹤0.01% |
48,330
+3,737
| +8% | +$140K |
|
1002
lululemon athletica
LULU
$10.6B
| $1.5M | ﹤0.01% |
5,316
+4,792
| +915% | +$1.76M |
|
1003
Carlisle Companies
CSL
$12.6B
| $1.5M | ﹤0.01% |
4,399
-1,592
| -27% | -$571K |
|
1004
MaxLinear
MXL
$6.3B
| $1.49M | ﹤0.01% |
+136,875
| New | +$2.29M |
|
1005
Curtiss-Wright
CW
$21.1B
| $1.49M | ﹤0.01% |
4,683
-15
| -0.3% | -$5.06K |
|
|
COOP
1006
DELISTED
Mr. Cooper
COOP
| $1.48M | ﹤0.01% |
12,405
-8,551
| -41% | -$893K |
|
|
SFD
1007
Smithfield Foods
SFD
$7.86B
| $1.48M | ﹤0.01% |
+72,546
| New | +$1.48M |
|
1008
Post Holdings
POST
$3.56B
| $1.48M | ﹤0.01% |
12,703
+753
| +6% | +$83.5K |
|
1009
APi Group
APG
$15.9B
| $1.48M | ﹤0.01% |
62,000
+5,954
| +11% | +$149K |
|
1010
Expeditors International
EXPD
$24.6B
| $1.48M | ﹤0.01% |
12,285
+3,203
| +35% | +$369K |
|
1011
Corcept Therapeutics
CORT
$12.1B
| $1.47M | ﹤0.01% |
12,872
-998
| -7% | -$60.7K |
|
1012
Real REMAX Group Inc. Common Stock
REAX
$415M
| $1.47M | ﹤0.01% |
36,165
-31,772
| -47% | -$1.51M |
|
1013
Viavi Solutions
VIAV
$8.51B
| $1.46M | ﹤0.01% |
130,345
-44,215
| -25% | -$492K |
|
1014
United Therapeutics
UTHR
$21.4B
| $1.45M | ﹤0.01% |
4,716
-2,362
| -33% | -$809K |
|
1015
Yelp
YELP
$1.13B
| $1.45M | ﹤0.01% |
39,129
+2,332
| +6% | +$87.7K |
|
1016
RenaissanceRe
RNR
$13.6B
| $1.45M | ﹤0.01% |
6,033
+1,541
| +34% | +$373K |
|
1017
Asbury Automotive
ABG
$3.5B
| $1.45M | ﹤0.01% |
6,546
-1,092
| -14% | -$285K |
|
1018
Western New England Bancorp
WNEB
$276M
| $1.42M | ﹤0.01% |
153,079
-16,255
| -10% | -$150K |
|
1019
DT Midstream
DTM
$12.8B
| $1.42M | ﹤0.01% |
14,675
-497
| -3% | -$49.7K |
|
1020
Park Hotels & Resorts
PK
$3B
| $1.41M | ﹤0.01% |
132,342
-16,850
| -11% | -$213K |
|
1021
Sabesp
SBS
$18.6B
| $1.41M | ﹤0.01% |
406,303
| – | – |
|
1022
Peapack-Gladstone Financial
PGC
$798M
| $1.39M | ﹤0.01% |
48,918
+213
| +0.4% | +$6.69K |
|
1023
BioMarin Pharmaceuticals
BMRN
$12.5B
| $1.39M | ﹤0.01% |
19,647
+648
| +3% | +$43.6K |
|
1024
i3 Verticals
IIIV
$265M
| $1.39M | ﹤0.01% |
56,292
-19,311
| -26% | -$489K |
|
1025
BioCryst Pharmaceuticals
BCRX
$2.15B
| $1.39M | ﹤0.01% |
184,904
+16,947
| +10% | +$137K |
|
Similar funds
Federated Hermes's Q1 2025 Portfolio in Review
As of Q1 2025, Federated Hermes held 2,237 positions worth $46.4B, up 1.5% from $45.7B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.34B of net new capital in Q1 2025, opening 170 new positions and adding to 888 existing holdings. Its largest new stake was Zscaler: 283,095 shares worth $56.2M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Gilead Sciences, an estimated $163M trimmed.
- Federated Hermes's largest Q1 2025 buy was Zscaler: 283,095 shares worth $56.2M.
- Federated Hermes added most to Amgen in Q1 2025, an estimated $197M increase.
- Federated Hermes's biggest Q1 2025 reduction was Gilead Sciences, cutting an estimated $163M.
- Federated Hermes fully exited New Fortress Energy in Q1 2025, selling an estimated $31.4M.
- Federated Hermes's ten largest holdings make up 15% of its $46.4B portfolio in Q1 2025.
- Federated Hermes opened 170 new positions and closed 187 in Q1 2025.
- Federated Hermes's portfolio value rose 1.5% quarter-over-quarter to $46.4B.
Based on Federated Hermes's 13F filing for Q1 2025, filed 8 May 2025.